After Hours
$
12.41
Change
+0.16 +1.31%
Volume
Volume 10,494
May 23, 2022, 6:45 p.m.
Quotes are delayed by 20 min
Previous close
$ 12.11
$ 12.25
Change
+0.14 +1.16%
Day low
Day high
$12.10
$12.50

52 week low
52 week high
$9.26
$24.00

Market cap
$806.31M
Average volume
499,804
P/E ratio
N/A
Rev. per Employee
$83,597
EPS
-1.36
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ACRS
-
Aclaris Therapeutics ugpraded to outperform from market perform at SVB Leerink
- Tomi Kilgore
-
Aclaris Therapeutics downgraded to market perform at Leerink
- Ciara Linnane
-
Aclaris Therapeutics started at outperform with $13 stock price target at SVB Leerink
- Tomi Kilgore
-
Why Pfizer’s Anacor Purchase is Good News for Dermira, Aclaris
- Barrons Blogs
-
If Valeant Sells Bausch & Lomb, Will Allergan Be a Bidder?
- Barrons Blogs
-
- Barron's Online
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For February 9, 2018
- Benzinga.com
-
- Benzinga.com
-
- Benzinga.com
Other News on ACRS
-
RA CAPITAL MANAGEMENT, L.P. Buys 4, Sells 1 in 1st Quarter
- GuruFocus.com
-
10-Q: ACLARIS THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Notable earnings before Tuesday's open
- Seeking Alpha
-
10-K: ACLARIS THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Notable earnings before Thursday's open
- Seeking Alpha
-
Aclaris Therapeutics appoints chief business officer
- Seeking Alpha
-
AREC, BZ and RVPH among mid-day movers
- Seeking Alpha
-
Aclaris falls on the exit of medical chief
- Seeking Alpha
- Loading more headlines...
Press Releases on ACRS
-
Aclaris Therapeutics Expands Leadership Team
- GlobeNewswire
-
Aclaris Therapeutics Provides R&D Update
- GlobeNewswire
-
- MarketNewsVideo.com
-
Aclaris Therapeutics to Host Virtual R&D Day on December 7, 2021
- GlobeNewswire
-
- MarketNewsVideo.com
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com